Data di Pubblicazione:
2018
Abstract:
The present invention is based on the finding that a camelid single domain antibody (sdAb) can be engineered for providing it with asparaginolytic activity; the obtained sdASNase molecule proved to be unexpectedly active and stable and could be targeted onto cancer cells by an antibody.
Tipologia CRIS:
6.1 Brevetto
Keywords:
T-CAN, catalytic antibodies, asparaginase.
Elenco autori:
Scotti, Claudia; Maggi, Maristella
Link alla scheda completa: